Part of Athagoras

Solving the IHD Challenge

Solving the IHD Challenge: Enabling Responsible Data Reuse in Life Sciences. By Mike Tatarnikov. MIGx AG

Basel, Switzerland – November 18, 2025 –
In this whitepaper, we show how the reuse of Individual Human Data can become compliant and scalable, reducing the friction of consent checks, inconsistent formats, and fragmented systems, and enabling researchers to request, receive, and use clinical data more efficiently.

Risks of AI in Life Sciences

Risks of AI in Life Sciences: Building, Buying and Balancing Control. MIGx AG. Roman Dushko.

Basel, Switzerland – October 28, 2025 –
In Life Sciences, adopting AI brings new questions of control and accountability. This blog explores the practical risks of building versus buying AI systems, and how governance, validation, and supplier oversight keep innovation compliant and under control.

Building a Security Strategy for Life Sciences

Building a Security Strategy in Life Sciences MIGx Roman Dushko

Basel, Switzerland – October 13, 2025 –
A security strategy only works when it shapes daily choices. In Life Sciences, it has to connect risk, frameworks, and lifecycle so that protection, compliance, and innovation move together. This blog looks at how to build strategies that stay active instead of gathering dust.

The Psychology of Knowledge Management

The Psychology of Knowledge Management: Barriers and Remedies – Applications to the Life Sciences Industry. MIGx. Cedric Berger

Basel, Switzerland – September 16, 2025 –
In this whitepaper, we explore how the psychology of knowledge management shapes decision-making in Life Sciences—addressing biases like overconfidence and automation bias, and highlighting remedies that enable safer, faster learning and more reliable outcomes.

Life Sciences Cybersecurity in 2025

Life Sciences Cybersecurity in 2025: Identity, Validation, Resilience and Usability. MIGx AG

Basel, Switzerland – August 28, 2025 –
AI may dominate the headlines in 2025, but Life Sciences cybersecurity still hinges on four enduring priorities: Identity, Validation, Resilience, and Usability.

Federated Governance Recommendation

Basel, Switzerland – July 17, 2025 –
Federated governance is often the hardest part of implementing data mesh—especially in Life Sciences.
In this blog, we share how MIGx helps biopharma organisations navigate decentralisation, balance risk, and build compliant, scalable data strategies tailored to the realities of regulated environments.

Navigating Complexities

Basel, Switzerland – July 16, 2025 –
In this whitepaper, we examine how genuine, data-centric transformation is key for Life Sciences and Biotech organizations to overcome digital complexity—unlocking scalable value from decades of siloed data and ensuring competitiveness in an AI-driven future.

Federated Governance in Life Sciences

Basel, Switzerland – July 2, 2025 –
How can federated governance work in biopharma?
Our latest blog explores key challenges and practical solutions for applying data mesh in the Life Sciences sector.

AI Prioritisation for Life Sciences

Basel, Switzerland – June 2, 2025 –
In this whitepaper, we explore how a risk-first approach enables Life Sciences organisations to overcome the POC bottleneck—shifting AI from isolated pilots to compliant, scalable deployment.

Mind the Language: Testing Agent Toxicity

Basel, Switzerland – May 13, 2025 –
In this blog, we explore how to approach multilingual toxicity assessment at scale — balancing AI-driven efficiency with human oversight, contextual accuracy, and cultural sensitivity.